Compare Lustrum:AnGes,Inc.:4563

※The values of financial statements might be different from the actual ones. Please confirm the original. [instructions]

Main FunctionHelp Company NameHelp CodeHelp Types of IndustryHelp Market Name Fiscal Year End Year of Listing
Browse U-Chart Add to 'Companies Comparison' list Compare Lustrum Ullet index AnGes,Inc. Go to web site 4563 Medicals 東証グロース December 1, 2000 2002.
Analysis u.gifU-Chart AnalysisHelp hikaku.gifAdd to 'Companies Comparison' listHelp u2.gifCompare LustrumHelp mark.gifUllet indexHelp
Accounts Information Balance Sheet Profit and Loss Account Cash Flow Statement
Display

AnGes,Inc. Balance Sheet(B/S)

[Show - Hide] U-Chart:Balance Sheet (B/S)Help Icon

【Left:Outgoing Money】 【Right:Incoming Money】

AnGes,Inc. Balance Sheet 2023年12月期 AnGes,Inc. Balance Sheet 2022年12月期 AnGes,Inc. Balance Sheet 2021年12月期 AnGes,Inc. Balance Sheet 2020年12月期 AnGes,Inc. Balance Sheet 2019年12月期

[Show - Hide] Balance Sheet (B/S)Help  ※Unit:Millions of Yen

Accounting Date December 31, 2023 December 31, 2022 December 31, 2021 December 31, 2020 December 31, 2019
Cash and Cash Equivalents
(Percent)
4,160down
(14.4%)down
11,035down
(28.4%)down
17,899up
(39.4%)up
11,537up
(30.1%)down
10,041
(80.2%)
Other Current AssetsHelp
(Percent)
1,761down
(6.1%)up
1,861down
(4.8%)down
3,527up
(7.8%)up
2,630up
(6.9%)down
952
(7.6%)
Tangible Fixed AssetsHelp
(Percent)
423down
(1.5%)down
1,411up
(3.6%)up
193down
(0.4%)down
236up
(0.6%)up
49
(0.4%)
Intangible Fixed AssetHelp
(Percent)
0
-
0
-
0
-
0
-
-0
(0.0%)
Investments and OthersHelp
(Percent)
802down
(2.8%)down
1,259up
(3.2%)up
1,161down
(2.6%)down
1,238up
(3.2%)up
-21,772
(-173.8%)
Total AssetsHelp
(Percent)
28,893
(100%)
38,821
(100%)
45,456
(100%)
38,355
(100%)
12,525
(100%)
Total Current LiabilitiesHelp
(Percent)
2,574down
(8.9%)down
7,400up
(19.1%)up
6,821up
(15.0%)up
5,675up
(14.8%)up
469
(3.7%)
Total Long-term LiabilitiesHelp
(Percent)
215down
(0.7%)down
995
(2.6%)
0
-
0
-
0
-
Shareholder's EquityHelp
(Percent)
26,103down
(90.3%)up
30,425down
(78.4%)down
38,635up
(85.0%)down
32,680up
(85.2%)down
12,055
(96.3%)
Total LiabilitiesHelp
(Percent)
28,893
(100%)
38,821
(100%)
45,456
(100%)
38,355
(100%)
12,525
(100%)

AnGes,Inc. Profit and Loss Account(P/L)

[表示非表示] U-Chart:Profit and Loss Account (P/L)Help Icon

【Left:Outgoing Money】 【Right:Incoming Money】

AnGes,Inc. Profit and Loss Account 2023年12月期 AnGes,Inc. Profit and Loss Account 2022年12月期 AnGes,Inc. Profit and Loss Account 2021年12月期 AnGes,Inc. Profit and Loss Account 2020年12月期 AnGes,Inc. Profit and Loss Account 2019年12月期

[Show - Hide] Profit and Loss Account (P/L)Help  ※Unit:Millions of Yen

Accounting Date December 31, 2023 December 31, 2022 December 31, 2021 December 31, 2020 December 31, 2019
Amount of Sales
(Percent)
153
(100%)
67
(100%)
64
(100%)
40
(100%)
327
(100%)
Total Sales
(Percent)
153
(100%)
67
(100%)
64
(100%)
40
(100%)
327
(100%)
Cost of SalesHelp
(Percent)
134up
(87.3%)down
94up
(140.0%)up
57up
(88.4%)up
23down
(57.6%)up
87
(26.7%)
Other Costs and RevenueHelp 7,457down
(4,874.4%)down
14,688up
(21,902.4%)up
13,683up
(21,330.4%)up
4,226up
(10,566.7%)up
3,990
(1,221.2%)
Total CostsHelp 7,591 14,782 13,740 4,250 4,078
Net RevenueHelp 19up
(12.7%)up
-27down
(-40.0%)down
7down
(11.6%)down
17down
(42.4%)down
240
(73.3%)
Earnings Before TaxHelp -7,471up
(-4,883.8%)up
-14,717down
(-21,945.7%)down
-13,735down
(-21,411.9%)down
-4,205down
(-10,512.9%)down
-3,752
(-1,148.1%)
Net IncomeHelp -7,438up
(-4,861.7%)up
-14,715down
(-21,942.4%)down
-13,676down
(-21,318.8%)down
-4,210down
(-10,524.3%)down
-3,751
(-1,147.9%)
当期純利益 -7,438 -14,715 -13,676 -4,210 -3,751

AnGes,Inc. Cash Flow Statement(C/F)

[表示非表示] U-Chart:Cash Flow Statement (C/F)Help Icon

【Left:Outgoing Money】 【Right:Incoming Money】

AnGes,Inc. Cash Flow Statement 2023年12月期 AnGes,Inc. Cash Flow Statement 2022年12月期 AnGes,Inc. Cash Flow Statement 2021年12月期 AnGes,Inc. Cash Flow Statement 2020年12月期 AnGes,Inc. Cash Flow Statement 2019年12月期

[Show - Hide] Cash Flow Statement (C/F)Help  ※Unit:Millions of Yen

Accounting Date December 31, 2023 December 31, 2022 December 31, 2021 December 31, 2020 December 31, 2019
Operating Cash Flow(OFC)Help
(Percent)
-8,746up
(-96.1%)up
-11,214up
(-99.1%)down
-11,381down
(-63.8%)down
-2,961down
(-25.9%)up
-2,180
(-28.4%)
Investing Cash Flow(ICF)Help
(Percent)
-357down
(-3.9%)down
-97up
(-0.9%)up
-155up
(-0.9%)up
-6,964down
(-61.0%)down
-1,250
(-16.3%)
Financing Cash FlowHelp
(Percent)
2,036down
(22.4%)down
3,573down
(31.6%)down
17,379up
(97.4%)down
11,404up
(99.8%)down
7,677
(99.9%)
Exchange Difference of Cash and Cash EquivalentsHelp
(Percent)
188down
(2.1%)down
873up
(7.7%)up
455up
(2.6%)up
18up
(0.2%)up
8
(0.1%)
Net Increase and Decrease in Cash and Cash Equivalentsn -6,878down
(-75.6%)down
-6,866down
(-60.7%)down
6,299up
(35.3%)up
1,496down
(13.1%)down
4,256
(55.4%)

他社比較Help

Companies in 'Companies Comparison' list

Browsing historyHelp

Your reecently viewed companies

AnGes,Inc.

Company where related level is highHelp

ASKA Pharmaceutical Co.,Ltd.
NANO MRNA Co., Ltd.
NIPPON CHEMIPHAR CO.,LTD.
Cyfuse Biomedical K.K.
Oncolys BioPharma Inc.
Modalis Therapeutics Corporation
FunPep Company Limited
Nichi-Iko Pharmaceutical Co.,Ltd.
Toyama Chemical Co.,Ltd.
Tsubota Laboratory Incorporated